TUCSON, Ariz.--(BUSINESS WIRE)--With the filing of its 3Q FY08 Financial Report on Form 10-QSB, CDEX Inc. (OTCBB: CEXI) announced revenues for the first nine months of FY08 that surpassed revenues for the entire FY2007. Revenues for the third quarter of FY2008 reported on the Form 10-QSB did not reflect international shipments of the ValiMed™ Model CCT because of a delay in receiving the TUV approval which, as previously announced, was granted with resulting international shipments of the ValiMed Model CCT in the 4th quarter. Accordingly, while year-to-date revenues for FY2008 exceeded revenues for all of FY2007, the 3rd quarter revenues were lower than expected. (The Form 10 QSB is accessible at www.cdexinc.com.)
